Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
74 hedge funds and large institutions have $118M invested in Marrone Bio Innovations, Inc. in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
69% more capital invested
Capital invested by funds: $69.8M → $118M (+$48.2M)
47% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 17
19% more funds holding
Funds holding: 62 → 74 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Allianz Asset Management
Munich,
Germany
|
+$3.21M |
| 2 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$1.54M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.28M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.21M |
| 5 |
BlackRock
New York
|
+$993K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$6.5M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$328K |
| 3 |
Renaissance Technologies
New York
|
-$141K |
| 4 |
Primecap Management
Pasadena,
California
|
-$96.4K |
| 5 |
GSC
Ground Swell Capital
Folly Beach,
South Carolina
|
-$30K |
MBII Hedge Fund Activity: Q1 2021 in Review
74 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q1 2021, worth a combined $118M — up 69% from $69.8M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new MBII positions and 5 closed out — a net gain of 12 holders — while 25 added to existing stakes and 17 trimmed.
The largest buyer was Allianz Asset Management, opening a new position worth an estimated $3.21M. The largest seller was Waddell & Reed Financial, cutting an estimated $6.5M.
- 74 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q1 2021, up from 62 in Q4 2020.
- Funds reported $118M of Marrone Bio Innovations, Inc. stock for Q1 2021, up 69% quarter-over-quarter.
- 17 funds opened new Marrone Bio Innovations, Inc. positions in Q1 2021 and 5 closed out, a net change of +12 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q1 2021 was Allianz Asset Management, an estimated $3.21M added.
- The largest Marrone Bio Innovations, Inc. seller in Q1 2021 was Waddell & Reed Financial, an estimated $6.5M sold.
Based on aggregated 13F filings for Q1 2021.